Phosphodiesterase Inhibition as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease: Where We Have Been and What Lies Ahead
Nicola A. Hanania, MD, MS1 Bartolomé R. Celli, MD2
Citation: Hanania NA, Celli BR. Phosphodiesterase inhibition as a therapeutic strategy for chronic obstructive pulmonary disease: where we have been and what lies ahead. Chronic Obstr Pulm Dis. 2024; Published online December 16, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0559
Prospective Randomized Study on Switching Triple Inhaler Therapy in COPD from Multiple Inhaler Devices to a Single Inhaler Device in a Chinese Population
Wang Chun Kwok, MBBS1 Ting Fung Ma, PhD2 Chung Ki Tsui, MPH1 James Chung Man Ho, MD1 Terence Chi Chun Tam, MBBS1
Citation: Kwok WC, Ma TF, Tsui CK, Ho JCM, Tam TCC. Prospective randomized study on switching triple inhaler therapy in COPD from multiple inhaler devices to a single inhaler device in a Chinese population. Chronic Obstr Pulm Dis. 2024; Published online December 13, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0519
Iron Deficiency and All-Cause Hospitalization Risk in a Clinical Cohort of COPD
Yukiko Kunitomo, MD1 Nirupama Putcha, MD, MHS1 Ashraf Fawzy, MD, MPH1 Sarath Raju, MD, MPH1 Meredith C. McCormack, MD, MHS1 Robert A. Wise, MD1 Nadia N. Hansel, MD, MPH1 Aparna Balasubramanian, MD, MHS1
Citation: Kunitomo Y, Putcha N, Fawzy A, et al. Iron deficiency and all-cause hospitalization risk in a clinical cohort of COPD. Chronic Obstr Pulm Dis. 2024; Published online December 13, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0550
Association Between Chronic Obstructive Pulmonary Disease and Mortality in Participants with Arthritis: Data from the National Health and Nutrition Examination Survey 1999–2018
Yingying Zhang, MM1 Guangxi Chen2 Aixia Huang, MM2 Ying Hu2 Chengfeng Fu, MM2,3
Citation: Zhang Y, Chen G, Huang A, Hu Y, Fu C. Association between chronic obstructive pulmonary disease and mortality in participants with arthritis: data from the National Health and Nutrition Examination Survey 1999–2018. Chronic Obstr Pulm Dis. 2024; Published online December 12, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0573
Effect of Common Medications on Longitudinal Pectoralis Muscle Area in Smokers
Toru Shirahata, MD1,2 Nicholas A. Enzer, BS1,3 Victor Castro, BS4 Joe Chiles, MD5 Merry-Lynn McDonald, PhD5,6,7 Bina Choi, MD1,3 Alejandro A. Diaz, MD, MPH1,3 George R. Washko, MD, MSc1,3 Raúl San José Estépar, PhD1,8 Samuel Y. Ash, MD, MPH9,10 Farbod N. Rahaghi, MD, PhD1,3
Citation: Shirahata T, Enzer NA, Castro V, et al. Effect of common medications on longitudinal pectoralis muscle area in smokers. Chronic Obstr Pulm Dis. 2024; Published online December 4, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0557
Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-world Data
Daniel N. Pfeffer, PhD
1 Rahul Dhakne, MS
2 Omnya El Massad, MSc
1 Pulkit Sehgal, BS
2 Thomas Ardiles, MD
3 Michael O. Calloway, PhD
4 M. Chris Runken, PharmD
4 Charlie Strange, MD
5,6 div>
Citation: Pfeffer DN, Dhakne R, El Massad O, et al. Improving the likelihood of identifying alpha-1 antitrypsin deficiency among patients with COPD: a novel predictive model using real-world data. Chronic Obstr Pulm Dis. 2024; Published online December 4, 2024. doi: https://doi.org/10.15326/jcopdf.2023.0491
Clinical Characteristics of Patients With COPD and Comorbid Depression and Anxiety: Data From a National Multicenter Cohort Study
Jing Gennie Wang1 Sonali Bose2,3 Janet T. Holbrook4 Lin Nan4 Michelle N. Eakin3 Abebaw M. Yohannes5,6 Robert A. Wise3 Nicola A. Hanania7 on behalf of the American Lung Association Airways Clinical Research Centers
Citation: Wang JG, Bose S, Holbrook JT, et al. Clinical characteristics of patients with COPD and comorbid depression and anxiety: data from a national multicenter cohort study. Chronic Obstr Pulm Dis. 2024; Published online December 4, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0534
KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency
Andrew J. Devine, BS1* Noah J. Smith, BS2* Rashika Joshi, MD3 Brandon Brooks-Patton4 Jenna Dunham, BS4 Ansley N. Varisco5 Emily M. Goodman, MD6 Qiang Fan, PhD3 Basilia Zingarelli, MD, PhD3 Brian M. Varisco, MD1,2,6,7
Citation: Devine AJ, Smith NJ, Joshi R, et al. KF4 anti-chymotrypsin-like elastase 1 antibody and purified alpha-1 antitrypsin have similar but not additive efficacy in preventing emphysema in murine alpha-1 antitrypsin deficiency. Chronic Obstr Pulm Dis. 2024; Published online November 26, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0535
Telerehabilitation Services Remain Increased Post-COVID-19 in Australia
Anthony K. May, PhD1 Anne E. Holland, PhD1,2,3 Jennifer A. Alison, PhD4 Kelcie Herrmann5 Narelle S. Cox, PhD1,2
Citation: May AK, Holland AE, Alison JA, Herrmann K, Cox NS. Telerehabilitation services remain increased post-COVID-19 in Australia. Chronic Obstr Pulm Dis. 2024; Published online November 26, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0575
Impact of Pharmacist Inhaler Prescribing at Discharge for Chronic Obstructive Pulmonary Disease on Readmission Rates
Ana-Maria Diaz, PharmD1 Lindsey M. Smith, PharmD, BCACP, BCCP1 Amber N. Peterson, Pulmonary APRN1 Macie L. Kent, PharmD, CACP, CPh1 Namitha J. Vellian, PharmD1
Citation: Diaz AM, Smith LM, Peterson AN, Kent ML, Vellian NJ. Impact of pharmacist inhaler prescribing at discharge for chronic obstructive pulmonary disease on readmission rates. Chronic Obstr Pulm Dis. 2024; Published online November 26, 2024. doi: https://doi.org/10.15326/jcopdf.2024.0553